牛嶋 公生 うしじま きみお 先生

来歴等

略歴

1983年 久留米大学医学部 卒業
1990年 医学博士取得
1990年 米国テキサス大学ダラス校留学
1992年 久留米大学産婦人科 助手
1999年 久留米大学産婦人科 講師
2004年 久留米大学産婦人科 助教授（現准教授）
2014年 久留米大学産婦人科 教授
2023年　久留米大学産婦人科 名誉教授
2023年　JCHO久留米総合病院院長補佐
2024年　JCHO久留米総合病院　病院長

論文

1.牛嶋公生：腎被膜下移植法による制癌剤感受性試験に関する研究。日本産科婦人科学会雑誌 41: 707-714, 1989
2.J Ian Mason, Kimio Ushijima, K. Nagai, D. Naville, JR.Head, L.Milewich, WE.Rainey, MM.Ralph：Regulation of expression of the 3-Hydroxysteroid Dehydrogenases of Human Placenta and Fetal Adrenal. J.Steroid Biochem. Molec.Biol 47: 151-159, 1993
3.牛嶋公生、杉山　徹、西田　敬、薬師寺道明、大蔵尚文、大渕盛夫、綱脇　現、蓮尾泰之、横田大介、天ヶ瀬紀昭、萩尾洋介、池田典文、駒井　幹、本村　聡：上皮性卵巣癌に対するSecond-look operation (SLO)の意義と問題点 日本産科婦人科学会雑誌 51(3): 119-126,1999
4.Kimio Ushijima, Syunichiro Ota, Kan Komai, Go Matsuo, Shigenobu Motoshima, Shizue Honda, Renpei Tomonari, Toru Sugiyama, Toshiharu Kamura: Clinical Assessment of Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Unresectable Advanced Ovarian Cancer. International Surgery 87:185-190, 2000
5.Xiao Huang, Kimio Ushijima, Kan Komai, Yumi Takemoto, Shigenobu Motoshima, Toshiharu Kamura, and Kimitoshi Kohno : Co-expression of Y-box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer. Gynecologic Oncology 93: 287-291,2004
6.Ushijima K，Yahata H，Yoshikawa H，Konishi I，Yasugi T，Saito T，Nakanishi T，Sasaki H，Saji F，Iwasaka T，Hatae M，Kodama S，Saito T，Terakawa N，Yaegashi N，Hiura M，Sakamoto A ，Tsuda H，Fukunaga M，Kamura T: Fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women : a multicenter phase II study . J Clin Oncol 25：2798-2803,2007
7.Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, Nishida N, Kakuma T, Tsuda H, Kasamatsu T, Sasajima Y, Kage M, Kuwano M, Kamura T :Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Letters 264: 36-43,2008
8.牛嶋　公生: 子宮体癌における高単位プロゲステロンによる妊孕性温存療法―治療効果および安全性、その後の妊娠について 長期観察結果―. 日本産科婦人科学会誌62: 2107-2114,2010
9.Kimio Ushijima,Toshiharu Kamura, Kazuo Tamura, Kazuo Kuzuya, Toru Sugiyama, Kichiro Noda, Kazunori Ochiai: Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and –resistant ovarian cancer: JGOG/WJGOG Intergroup Study. Int J Clin Oncol 18: 126-131,2013
10.Tsuda N，Ushijima K，Kawano K，Takemoto S，Nishio S，Sonoda G，KamuraT: Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device.J Gynecol Oncol 25(3):229 - 235，2014
11.Ushijima K，Kawano K，Tsuda N，Nishio S，Terada A，Kato H，Matsukuma K: Epithelial borderline ovarian tumor: Diagnosis and treatment strategy. Obstetrics & Gynecolgy Science 58(3):183 - 187，2015
12.Kojiro-Sanada S，Yasuda K，Nishio S，Ogasawara S，Akiba J，Ushijima K，Yano H:CXCL14-CXCR4 and CXCL12-CXCR4 axes may play important roles in the unique invasion process of endometrioid carcinoma with MELF-pattern myoinvasion.Int J Gynecol Pathol 36(6):530 - 539，2017
13.Nishio S，Takekuma M，Takeuchi S，Kawano K，Tsuda N，Tasaki K，Takahashi N，Abe M，Tanaka A，Nagasawa T，Shoji T，Xiong H，Nuthalapati S，Leahy T，Hashiba H，Kiriyama T，Komarnitsky P，Hirashima Y，Ushijima K: Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer. Cancer Sci 108(11): 2213 - 2220，2017
14.Ushijima K: Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy. J Gynecol Oncol 30(6)，e117，2019
15.Nishio S，Ushijima K: Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer. Japanese Journal of Clinical Oncology 50(4): 379 - 386，2020
16.Nakanishi T，Saito T，Aoki D，Watanabe Y，Ushijima K，Takano M，Sugiyama T，Yaegashi N，Takehara K JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer.
Int J Clin Oncol, 28, 436 - 444，2023
17.Ushijima K，Tsuda N，Yamagami W，Mitsuhashi A，Mikami M，Yaegashi N，Enomoto T　Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology.
J Gynecol Oncol, 34, e38，2023
18.Tse KY, Ushijima K, Tan AL, Intasorn P, Pariyar J, Chang CL, Domingo EJ, Konar H, Kumarasamy S, Tjokroprawiro BA, Wilailak S.　A questionnaire study on disparity of cervical cancer prevention programs in Asia-Oceania.
J Obstet Gynecol Res, 49, 1230 - 1243，2023
19.Nishio S, Ushijima K , Ishikawa M , Tokunaga H , Horie K , Yamaguchi S , Suzuki S , YahataH , Tsuda H , Satoh T Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study J Gynecol Oncol. 36(6):e93 2025